Week Ending January 24, 2022

Major Progress In Lung Cancer Early Detection and Treatment Facilitates Drop in Overall Cancer Mortality
“There’s major progress in the fight against lung cancer. Although lung cancer continues to be the leading cause of cancer death, patients are finally being diagnosed earlier and living longer. This was one of the major findings in Cancer Statistics, 2022, the latest edition of the American Cancer Society’s annual report on cancer rates and trends released today.”

State bill being debated with Ky. having highest lung cancer rates in US
“FRANKFORT, Ky. (FOX 56) – Kentucky has the highest lung cancer rates in the country.
A new plan in the General Assembly hopes to change that. A bill being debated would make state money available to help anyone who needs a lung cancer screening.”

Using Immunotherapy to Treat Lung Cancer
“A study explained the growing importance of immunotherapy as a therapeutic approach to treat cancer, where several phase III studies exhibited survival advantages and castration-resistant prostate cancer.”

Completion of CT lung screening varies between groups in Hawaii
“January 20, 2022 — Participation in CT lung cancer screening varied among Native Hawaiian, Pacific Islander, and Asian individuals in a population-based study out of Hawaii published January 20 in JAMA Network Open.”

Approaches and Obstacles to Frontline Treatment for Small Cell Lung Cancer
“A 73-year–old woman presented with shortness of breath, productive cough, chest pain, fatigue, anorexia, and recent 18-lb weight loss. She had a history of hypertension and was a 45 pack-a-year smoker. An examination showed she had dullness to percussion and decreased breath sounds.”

Smoking cessation at time of lung cancer diagnosis associated with improved survival
“Smoking cessation initiated around the time of a lung cancer diagnosis is associated with an improved overall survival from the disease.”

Diagnosed with Non-Small-Cell Lung Cancer? Here’s Why You Need Biomarker Testing
“Testing for biomarkers can uncover more about your lung cancer, allowing doctors to personalize treatment to your unique cancer type.”

Finding Emotional Support Following a Non-Small-Cell Lung Cancer Diagnosis
“The importance of mental health cannot be underestimated when it comes to coping with a lung cancer diagnosis.”

Pembrolizumab Shows Improvements in Disease-Free Survival as Adjuvant Treatment for Non-Small Cell Lung Cancer
“New study results with adjuvant pembrolizumab show statistically significant improvements in disease-free survival (DFS) among patients with stage IB-IIIA non-small cell lung cancer (NSCLC) regardless of programmed death-ligand 1 (PD-L1) expression, according to a press release from Merck.”

Sugemalimab plus chemo boosts lung cancer survival, trial reveals
“The GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 antibody, sugemalimab, in combination with chemotherapy as a first-line treatment for patients with stage four non-small cell lung cancer (NSCLC), versus using chemotherapy alone.”